{"id":141342,"date":"2018-04-09T10:14:38","date_gmt":"2018-04-09T10:14:38","guid":{"rendered":"https:\/\/stg.strategist1trial.com\/ensayo-strategist3\/"},"modified":"2026-03-17T16:44:06","modified_gmt":"2026-03-17T16:44:06","slug":"ensayo-strategist3","status":"publish","type":"page","link":"https:\/\/stg.strategist3trial.com\/es-us\/","title":{"rendered":"Ensayo StrateGIST3"},"content":{"rendered":"<div class=\"wpb-content-wrapper\"><p>[vc_row row_height_percent=&#8221;100&#8243; back_color=&#8221;color-138503&#8243; back_image=&#8221;112255&#8243; back_repeat=&#8221;no-repeat&#8221; back_attachment=&#8221;scroll&#8221; back_position=&#8221;center center&#8221; parallax=&#8221;yes&#8221; overlay_alpha=&#8221;50&#8243; gutter_size=&#8221;4&#8243; column_width_percent=&#8221;100&#8243; shift_y=&#8221;0&#8243; z_index=&#8221;0&#8243; enable_bottom_divider=&#8221;default&#8221; bottom_divider_inv=&#8221;tilt&#8221; shape_bottom_invert=&#8221;yes&#8221; shape_bottom_flip=&#8221;yes&#8221; shape_bottom_h_use_pixel=&#8221;&#8221; shape_bottom_height=&#8221;100&#8243; shape_bottom_color=&#8221;color-681992&#8243; shape_bottom_opacity=&#8221;100&#8243; shape_bottom_index=&#8221;0&#8243; medium_visibility=&#8221;yes&#8221; mobile_visibility=&#8221;yes&#8221; el_class=&#8221;gradient&#8221; uncode_shortcode_id=&#8221;821871&#8243; back_color_type=&#8221;uncode-palette&#8221; shape_bottom_color_type=&#8221;uncode-palette&#8221; row_name=&#8221;iphone&#8221;][vc_column column_width_use_pixel=&#8221;yes&#8221; position_vertical=&#8221;bottom&#8221; align_horizontal=&#8221;align_center&#8221; gutter_size=&#8221;3&#8243; expand_height=&#8221;yes&#8221; style=&#8221;dark&#8221; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;7&#8243; align_mobile=&#8221;align_center_mobile&#8221; mobile_width=&#8221;0&#8243; css_animation=&#8221;bottom-t-top&#8221; animation_delay=&#8221;200&#8243; width=&#8221;1\/1&#8243; uncode_shortcode_id=&#8221;177675&#8243; column_width_pixel=&#8221;1000&#8243;][vc_empty_space empty_h=&#8221;5&#8243;][vc_single_image media=&#8221;138432&#8243; media_width_percent=&#8221;36&#8243; alignment=&#8221;center&#8221; uncode_shortcode_id=&#8221;624267&#8243;][vc_column_text text_color=&#8221;color-jevc&#8221; uncode_shortcode_id=&#8221;137548&#8243; text_color_type=&#8221;uncode-palette&#8221;]El IDRX-42 (GSK6042981) es un inhibidor altamente selectivo y potente de la prote\u00edna KIT, que es hiperactiva en muchas personas con GIST, lo que provoca el crecimiento y la acumulaci\u00f3n de las c\u00e9lulas cancerosas.[\/vc_column_text][\/vc_column][\/vc_row][vc_row row_height_percent=&#8221;100&#8243; back_color=&#8221;color-138503&#8243; back_image=&#8221;112267&#8243; back_repeat=&#8221;no-repeat&#8221; back_attachment=&#8221;fixed&#8221; back_position=&#8221;center top&#8221; overlay_alpha=&#8221;50&#8243; gutter_size=&#8221;4&#8243; column_width_percent=&#8221;100&#8243; shift_y=&#8221;0&#8243; z_index=&#8221;0&#8243; enable_bottom_divider=&#8221;default&#8221; bottom_divider_inv=&#8221;tilt&#8221; shape_bottom_invert=&#8221;yes&#8221; shape_bottom_h_use_pixel=&#8221;&#8221; shape_bottom_height=&#8221;100&#8243; shape_bottom_color=&#8221;color-681992&#8243; shape_bottom_opacity=&#8221;100&#8243; shape_bottom_index=&#8221;0&#8243; desktop_visibility=&#8221;yes&#8221; mobile_visibility=&#8221;yes&#8221; row_name=&#8221;iphone&#8221; el_class=&#8221;gradient&#8221; uncode_shortcode_id=&#8221;159258&#8243; back_color_type=&#8221;uncode-palette&#8221; shape_bottom_color_type=&#8221;uncode-palette&#8221;][vc_column column_width_use_pixel=&#8221;yes&#8221; position_vertical=&#8221;middle&#8221; align_horizontal=&#8221;align_center&#8221; gutter_size=&#8221;3&#8243; style=&#8221;dark&#8221; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;7&#8243; align_mobile=&#8221;align_center_mobile&#8221; mobile_width=&#8221;0&#8243; css_animation=&#8221;bottom-t-top&#8221; animation_delay=&#8221;200&#8243; width=&#8221;1\/1&#8243; uncode_shortcode_id=&#8221;276875&#8243; column_width_pixel=&#8221;1000&#8243;][vc_empty_space empty_h=&#8221;1&#8243;][vc_single_image media=&#8221;138432&#8243; media_width_percent=&#8221;45&#8243; alignment=&#8221;center&#8221; uncode_shortcode_id=&#8221;927066&#8243;][vc_empty_space empty_h=&#8221;1&#8243;][vc_button button_color=&#8221;color-681992&#8243; border_width=&#8221;0&#8243; uncode_shortcode_id=&#8221;321186&#8243; width=&#8221;216&#8243; link=&#8221;url:%23study-description|title:FAQs|&#8221; button_color_type=&#8221;uncode-palette&#8221;]M\u00e1s informaci\u00f3n[\/vc_button][vc_empty_space empty_h=&#8221;2&#8243;][vc_column_text text_color=&#8221;color-196438&#8243; uncode_shortcode_id=&#8221;111155&#8243; text_color_type=&#8221;uncode-palette&#8221;]Haga clic aqu\u00ed para ver un video sobre StrateGIST 3, que incluye la finalidad del estudio, qui\u00e9n puede participar en \u00e9l, los medicamentos del estudio y qu\u00e9 esperar durante el mismo.[\/vc_column_text][vc_single_image media=&#8221;123031&#8243; media_width_percent=&#8221;100&#8243; uncode_shortcode_id=&#8221;157773&#8243;][\/vc_column][\/vc_row][vc_row row_height_percent=&#8221;100&#8243; back_color=&#8221;color-138503&#8243; back_image=&#8221;112266&#8243; back_attachment=&#8221;scroll&#8221; back_position=&#8221;center bottom&#8221; parallax=&#8221;yes&#8221; overlay_alpha=&#8221;50&#8243; gutter_size=&#8221;4&#8243; column_width_percent=&#8221;100&#8243; shift_y=&#8221;0&#8243; z_index=&#8221;0&#8243; enable_bottom_divider=&#8221;default&#8221; bottom_divider_inv=&#8221;tilt&#8221; shape_bottom_invert=&#8221;yes&#8221; shape_bottom_h_use_pixel=&#8221;&#8221; shape_bottom_height=&#8221;100&#8243; shape_bottom_color=&#8221;color-681992&#8243; shape_bottom_opacity=&#8221;100&#8243; shape_bottom_index=&#8221;0&#8243; desktop_visibility=&#8221;yes&#8221; medium_visibility=&#8221;yes&#8221; row_name=&#8221;iphone&#8221; el_class=&#8221;gradient&#8221; uncode_shortcode_id=&#8221;204395&#8243; back_color_type=&#8221;uncode-palette&#8221; shape_bottom_color_type=&#8221;uncode-palette&#8221;][vc_column column_width_use_pixel=&#8221;yes&#8221; position_vertical=&#8221;middle&#8221; align_horizontal=&#8221;align_center&#8221; gutter_size=&#8221;3&#8243; style=&#8221;dark&#8221; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;7&#8243; align_mobile=&#8221;align_center_mobile&#8221; mobile_width=&#8221;0&#8243; css_animation=&#8221;bottom-t-top&#8221; animation_delay=&#8221;200&#8243; width=&#8221;1\/1&#8243; uncode_shortcode_id=&#8221;276875&#8243; column_width_pixel=&#8221;1000&#8243;][vc_empty_space empty_h=&#8221;1&#8243;][vc_single_image media=&#8221;138432&#8243; media_width_percent=&#8221;60&#8243; alignment=&#8221;center&#8221; uncode_shortcode_id=&#8221;482822&#8243;][vc_button button_color=&#8221;color-681992&#8243; border_width=&#8221;0&#8243; uncode_shortcode_id=&#8221;155178&#8243; width=&#8221;216&#8243; link=&#8221;url:%23study-description|title:FAQs|&#8221; button_color_type=&#8221;uncode-palette&#8221;]M\u00e1s informaci\u00f3n[\/vc_button][vc_empty_space empty_h=&#8221;0&#8243;][vc_column_text text_color=&#8221;color-196438&#8243; uncode_shortcode_id=&#8221;111155&#8243; text_color_type=&#8221;uncode-palette&#8221;]Haga clic aqu\u00ed para ver un video sobre StrateGIST 3, que incluye la finalidad del estudio, qui\u00e9n puede participar en \u00e9l, los medicamentos del estudio y qu\u00e9 esperar durante el mismo.[\/vc_column_text][vc_empty_space empty_h=&#8221;0&#8243;][vc_single_image media=&#8221;123031&#8243; media_width_percent=&#8221;100&#8243; uncode_shortcode_id=&#8221;157773&#8243;][\/vc_column][\/vc_row][vc_row row_height_percent=&#8221;50&#8243; override_padding=&#8221;yes&#8221; h_padding=&#8221;2&#8243; top_padding=&#8221;4&#8243; bottom_padding=&#8221;3&#8243; back_color=&#8221;color-681992&#8243; overlay_alpha=&#8221;50&#8243; gutter_size=&#8221;3&#8243; column_width_percent=&#8221;100&#8243; shift_y=&#8221;0&#8243; z_index=&#8221;0&#8243; bottom_divider=&#8221;tilt&#8221; uncode_shortcode_id=&#8221;168548&#8243; back_color_type=&#8221;uncode-palette&#8221; row_name=&#8221;study-description&#8221;][vc_column column_width_use_pixel=&#8221;yes&#8221; position_vertical=&#8221;middle&#8221; align_horizontal=&#8221;align_center&#8221; gutter_size=&#8221;3&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; width=&#8221;1\/1&#8243; column_width_pixel=&#8221;1000&#8243; uncode_shortcode_id=&#8221;145453&#8243;][vc_custom_heading text_color=&#8221;color-138503&#8243; heading_semantic=&#8221;h1&#8243; desktop_visibility=&#8221;yes&#8221; medium_visibility=&#8221;yes&#8221; mobile_visibility=&#8221;yes&#8221; uncode_shortcode_id=&#8221;671518&#8243; text_color_type=&#8221;uncode-palette&#8221;]<strong>\u00bfQu\u00e9 es StrateGIST 3?<\/strong>[\/vc_custom_heading][vc_column_text text_color=&#8221;color-xsdn&#8221; uncode_shortcode_id=&#8221;775611&#8243; text_color_type=&#8221;uncode-palette&#8221;]<span style=\"font-weight: 400;\"><strong style=\"font-size: 20px; color: #ffffff;\">StrateGIST 3<\/strong> es un ensayo cl\u00ednico que prueba un medicamento experimental (medicamento del estudio) llamado IDRX-42 (GSK6042981) en adultos con tumores del estroma gastrointestinal (GIST, por sus siglas en ingl\u00e9s) metast\u00e1sicos y\/o no resecables que han progresado o que no toleraron el tratamiento de primera l\u00ednea con imatinib.<\/span> <span style=\"font-weight: 400;\">Los investigadores quieren saber m\u00e1s sobre la seguridad del IDRX-42 (GSK6042981) y comparar sus efectos con el sunitinib, que es un tratamiento aprobado en algunos pa\u00edses para el tipo de GIST que se est\u00e1 estudiando.<\/span> <span style=\"font-weight: 400;\">Este ensayo se basar\u00e1 en lo aprendido sobre IDRX-42 (GSK6042981) en un&nbsp;ensayo anterior en personas con GIST.<\/span>[\/vc_column_text][vc_column_text text_color=&#8221;color-xsdn&#8221; uncode_shortcode_id=&#8221;246950&#8243; text_color_type=&#8221;uncode-palette&#8221;]El video a continuaci\u00f3n ofrece generalidades sobre StrateGIST 3, que incluyen la finalidad del estudio, qui\u00e9n puede participar en \u00e9l, los medicamentos del estudio y qu\u00e9 esperar durante el mismo.[\/vc_column_text][vc_empty_space empty_h=&#8221;3&#8243;][vc_button button_color=&#8221;color-196438&#8243; border_animation=&#8221;btn-ripple-out&#8221; border_width=&#8221;0&#8243; display=&#8221;inline&#8221; link=&#8221;url:%23location|title:Join%20the%20Study|&#8221; button_color_type=&#8221;uncode-palette&#8221; width=&#8221;216&#8243; uncode_shortcode_id=&#8221;132884&#8243;]Encuentre un centro del ensayo cl\u00ednico[\/vc_button][\/vc_column][\/vc_row][vc_row row_height_percent=&#8221;0&#8243; override_padding=&#8221;yes&#8221; h_padding=&#8221;2&#8243; top_padding=&#8221;7&#8243; bottom_padding=&#8221;7&#8243; back_color=&#8221;color-138503&#8243; overlay_alpha=&#8221;50&#8243; gutter_size=&#8221;4&#8243; column_width_percent=&#8221;100&#8243; shift_y=&#8221;0&#8243; z_index=&#8221;0&#8243; enable_top_divider=&#8221;default&#8221; top_divider=&#8221;tilt&#8221; shape_top_h_use_pixel=&#8221;&#8221; shape_top_height=&#8221;100&#8243; shape_top_color=&#8221;color-681992&#8243; shape_top_opacity=&#8221;100&#8243; shape_top_index=&#8221;0&#8243; enable_bottom_divider=&#8221;default&#8221; bottom_divider=&#8221;tilt&#8221; shape_bottom_h_use_pixel=&#8221;&#8221; shape_bottom_height=&#8221;150&#8243; shape_bottom_opacity=&#8221;100&#8243; shape_bottom_index=&#8221;0&#8243; desktop_visibility=&#8221;yes&#8221; medium_visibility=&#8221;yes&#8221; mobile_visibility=&#8221;yes&#8221; uncode_shortcode_id=&#8221;152579&#8243; back_color_type=&#8221;uncode-palette&#8221; shape_top_color_type=&#8221;uncode-palette&#8221;][vc_column column_width_percent=&#8221;100&#8243; gutter_size=&#8221;3&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; sticky=&#8221;yes&#8221; width=&#8221;1\/2&#8243; uncode_shortcode_id=&#8221;179542&#8243;][vc_row_inner limit_content=&#8221;&#8221;][vc_column_inner column_width_percent=&#8221;100&#8243; position_horizontal=&#8221;right&#8221; gutter_size=&#8221;3&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; width=&#8221;1\/1&#8243; uncode_shortcode_id=&#8221;242247&#8243;][vc_custom_heading text_size=&#8221;&#8221; uncode_shortcode_id=&#8221;506177&#8243;]<strong>\u00bfQu\u00e9 ocurre durante el ensayo?<\/strong>[\/vc_custom_heading][\/vc_column_inner][\/vc_row_inner][vc_column_text uncode_shortcode_id=&#8221;183718&#8243;]<span style=\"font-weight: 400\">El ensayo probar\u00e1 el medicamento del estudio, IDRX-42, en adultos con GIST metast\u00e1sico y\/o no resecable que ha progresado mientras tomaban imatinib o que no toleran los efectos secundarios del imatinib. El objetivo es comparar los efectos del IDRX-42 versus el sunitinib.<\/span><\/p>\n<p><span style=\"font-weight: 400\">IDRX-42 es un medicamento del estudio y no ha sido aprobado por ninguna autoridad de salud para su uso fuera de un ensayo cl\u00ednico.<\/span>[\/vc_column_text][vc_empty_space empty_h=&#8221;4&#8243;][\/vc_column][vc_column column_width_percent=&#8221;95&#8243; gutter_size=&#8221;3&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; css_animation=&#8221;alpha-anim&#8221; width=&#8221;1\/2&#8243; uncode_shortcode_id=&#8221;900895&#8243;][vc_custom_heading text_size=&#8221;h3&#8243; uncode_shortcode_id=&#8221;954054&#8243;]Consentimiento informado[\/vc_custom_heading][vc_column_text uncode_shortcode_id=&#8221;195636&#8243;]<span style=\"font-weight: 400\">Antes de que decida si desea participar, el equipo del estudio revisar\u00e1 los detalles del ensayo con usted. Esto incluye los posibles riesgos y beneficios y lo que puede esperar si participa. Si decide participar, le pedir\u00e1n que firme un Formulario de consentimiento informado. Esto confirma que entiende el ensayo y que est\u00e1 dispuesto a participar para determinar si es elegible.<\/span>[\/vc_column_text][vc_separator sep_color=&#8221;color-prif&#8221; uncode_shortcode_id=&#8221;169390&#8243; sep_color_type=&#8221;uncode-palette&#8221;][vc_custom_heading text_size=&#8221;h3&#8243; uncode_shortcode_id=&#8221;178847&#8243;]Selecci\u00f3n[\/vc_custom_heading][vc_column_text uncode_shortcode_id=&#8221;350149&#8243;]<span style=\"font-weight: 400\">Para ver si califica, tendr\u00e1 al menos 1 visita al centro del estudio para responder a preguntas sobre su salud y los medicamentos que toma, y para someterse a algunas pruebas.<\/span>[\/vc_column_text][vc_separator sep_color=&#8221;color-prif&#8221; uncode_shortcode_id=&#8221;169390&#8243; sep_color_type=&#8221;uncode-palette&#8221;][vc_custom_heading text_size=&#8221;h3&#8243; uncode_shortcode_id=&#8221;209503&#8243;]Tratamiento del estudio[\/vc_custom_heading][vc_column_text uncode_shortcode_id=&#8221;132873&#8243;]<span style=\"font-weight: 400\">Si califica para el ensayo, le colocar\u00e1n por azar en un grupo para que reciba o bien IDRX-42 o bien sunitinib (el tratamiento aprobado).&nbsp;<\/span><\/p>\n<p><span style=\"font-weight: 400\">IDRX-42 se suministra en forma de comprimidos que se toman por boca una vez al d\u00eda en casa. El IDRX-42 se toma todos los d\u00edas. El sunitinib se toma durante 28 d\u00edas seguidos, y a continuaci\u00f3n se realiza una pausa de 14 d\u00edas (a menos que su m\u00e9dico le d\u00e9 otras indicaciones)&nbsp;<\/span>.<\/p>\n<p><span style=\"font-weight: 400\">Durante el periodo de tratamiento del estudio, usted asistir\u00e1 al centro del estudio para chequear su estado de salud y c\u00f3mo est\u00e1 respondiendo su c\u00e1ncer al tratamiento del estudio (IDRX-42 o sunitinib).<\/span><\/p>\n<p><span style=\"font-weight: 400\">Si est\u00e1 tomando sunitinib y su c\u00e1ncer empeora, es posible que pueda cambiar a IDRX-42.<\/span><\/p>\n<p><strong>El patrocinador del ensayo cl\u00ednico pagar\u00e1 el tratamiento del estudio (IDRX-42 o sunitinib), las visitas y las pruebas relacionadas con el estudio. Habr\u00e1 reembolso de los gastos de viaje relacionados con las visitas del estudio.<\/strong>[\/vc_column_text][vc_separator sep_color=&#8221;color-prif&#8221; uncode_shortcode_id=&#8221;447472&#8243; sep_color_type=&#8221;uncode-palette&#8221;][vc_custom_heading text_size=&#8221;h3&#8243; uncode_shortcode_id=&#8221;165143&#8243;]Seguimiento[\/vc_custom_heading][vc_column_text uncode_shortcode_id=&#8221;435261&#8243;]<span style=\"font-weight: 400\">Una vez que usted y su m\u00e9dico decidan interrumpir el tratamiento del estudio, tendr\u00e1 2 visitas m\u00e1s y mantendr\u00e1 llamadas telef\u00f3nicas con el equipo del estudio cada 3 meses.<\/span>[\/vc_column_text][vc_empty_space empty_h=&#8221;2&#8243;][vc_button button_color=&#8221;color-681992&#8243; border_animation=&#8221;btn-ripple-out&#8221; border_width=&#8221;0&#8243; uncode_shortcode_id=&#8221;626023&#8243; link=&#8221;url:https%3A%2F%2Fstg.strategist1trial.com%2Ffaqs-2%2F|title:FAQs|&#8221; button_color_type=&#8221;uncode-palette&#8221;]Explore las preguntas frecuentes sobre StrateGIST\u00a03[\/vc_button][vc_empty_space empty_h=&#8221;2&#8243;][\/vc_column][\/vc_row][vc_row row_height_percent=&#8221;0&#8243; back_color=&#8221;color-138503&#8243; overlay_alpha=&#8221;50&#8243; gutter_size=&#8221;4&#8243; column_width_percent=&#8221;100&#8243; shift_y=&#8221;0&#8243; z_index=&#8221;0&#8243; enable_top_divider=&#8221;default&#8221; top_divider=&#8221;tilt&#8221; shape_top_h_use_pixel=&#8221;&#8221; shape_top_height=&#8221;100&#8243; shape_top_color=&#8221;color-681992&#8243; shape_top_opacity=&#8221;100&#8243; shape_top_index=&#8221;0&#8243; enable_bottom_divider=&#8221;default&#8221; bottom_divider=&#8221;tilt&#8221; shape_bottom_h_use_pixel=&#8221;&#8221; shape_bottom_height=&#8221;150&#8243; shape_bottom_opacity=&#8221;100&#8243; shape_bottom_index=&#8221;0&#8243; uncode_shortcode_id=&#8221;944839&#8243; back_color_type=&#8221;uncode-palette&#8221; shape_top_color_type=&#8221;uncode-palette&#8221;][vc_column column_width_percent=&#8221;100&#8243; align_horizontal=&#8221;align_center&#8221; gutter_size=&#8221;3&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; sticky=&#8221;yes&#8221; width=&#8221;1\/1&#8243; uncode_shortcode_id=&#8221;580905&#8243;][vc_row_inner limit_content=&#8221;&#8221;][vc_column_inner column_width_percent=&#8221;100&#8243; position_horizontal=&#8221;right&#8221; position_vertical=&#8221;middle&#8221; align_horizontal=&#8221;align_center&#8221; gutter_size=&#8221;3&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; width=&#8221;1\/1&#8243; uncode_shortcode_id=&#8221;111259&#8243;][vc_empty_space empty_h=&#8221;3&#8243;][vc_custom_heading text_size=&#8221;&#8221; uncode_shortcode_id=&#8221;506177&#8243;]<strong>\u00bfQu\u00e9 ocurre durante el ensayo?<\/strong>[\/vc_custom_heading][vc_column_text uncode_shortcode_id=&#8221;105390&#8243;]<span style=\"font-weight: 400;\">El ensayo probar\u00e1 el medicamento del estudio, IDRX-42 (GSK6042981), en adultos con GIST metast\u00e1sico y\/o no resecable que ha progresado mientras tomaban imatinib o que no toleran los efectos secundarios del imatinib. El objetivo es comparar la seguridad y los efectos del IDRX-42 (GSK6042981) versus el sunitinib.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">IDRX-42 (GSK6042981) es un medicamento del estudio y no ha sido aprobado por ninguna autoridad de salud para su uso fuera de un ensayo cl\u00ednico.<\/span>[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][vc_row_inner limit_content=&#8221;&#8221;][vc_column_inner column_width_percent=&#8221;100&#8243; align_horizontal=&#8221;align_center&#8221; gutter_size=&#8221;3&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; width=&#8221;1\/1&#8243; uncode_shortcode_id=&#8221;158094&#8243;][vc_custom_heading uncode_shortcode_id=&#8221;175823&#8243;]Su recorrido en StrateGIST\u00a03[\/vc_custom_heading][\/vc_column_inner][\/vc_row_inner][vc_row_inner row_inner_height_percent=&#8221;0&#8243; overlay_alpha=&#8221;50&#8243; gutter_size=&#8221;3&#8243; shift_y=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_visibility=&#8221;yes&#8221; mobile_visibility=&#8221;yes&#8221; limit_content=&#8221;&#8221; uncode_shortcode_id=&#8221;663441&#8243;][vc_column_inner column_width_percent=&#8221;100&#8243; align_horizontal=&#8221;align_center&#8221; gutter_size=&#8221;3&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; width=&#8221;1\/1&#8243; uncode_shortcode_id=&#8221;158744&#8243;][vc_single_image media=&#8221;141349&#8243; media_width_percent=&#8221;85&#8243; alignment=&#8221;center&#8221; uncode_shortcode_id=&#8221;116373&#8243;][vc_single_image media=&#8221;141372&#8243; media_width_percent=&#8221;85&#8243; alignment=&#8221;center&#8221; uncode_shortcode_id=&#8221;830644&#8243;][vc_single_image media=&#8221;141395&#8243; media_width_percent=&#8221;85&#8243; alignment=&#8221;center&#8221; uncode_shortcode_id=&#8221;122222&#8243;][vc_single_image media=&#8221;141418&#8243; media_width_percent=&#8221;85&#8243; alignment=&#8221;center&#8221; uncode_shortcode_id=&#8221;121225&#8243;][\/vc_column_inner][\/vc_row_inner][vc_row_inner row_inner_height_percent=&#8221;0&#8243; overlay_alpha=&#8221;50&#8243; gutter_size=&#8221;3&#8243; shift_y=&#8221;0&#8243; z_index=&#8221;0&#8243; desktop_visibility=&#8221;yes&#8221; limit_content=&#8221;&#8221; uncode_shortcode_id=&#8221;143909&#8243;][vc_column_inner width=&#8221;1\/1&#8243;][vc_single_image media=&#8221;138552&#8243; media_width_percent=&#8221;85&#8243; alignment=&#8221;center&#8221; uncode_shortcode_id=&#8221;165287&#8243;][vc_single_image media=&#8221;138492&#8243; media_width_percent=&#8221;11&#8243; alignment=&#8221;center&#8221; uncode_shortcode_id=&#8221;197707&#8243;][vc_single_image media=&#8221;138532&#8243; media_width_percent=&#8221;85&#8243; alignment=&#8221;center&#8221; uncode_shortcode_id=&#8221;840834&#8243;][vc_single_image media=&#8221;138492&#8243; media_width_percent=&#8221;11&#8243; alignment=&#8221;center&#8221; uncode_shortcode_id=&#8221;746250&#8243;][vc_single_image media=&#8221;112312&#8243; media_width_percent=&#8221;85&#8243; alignment=&#8221;center&#8221; uncode_shortcode_id=&#8221;108810&#8243;][vc_single_image media=&#8221;138492&#8243; media_width_percent=&#8221;11&#8243; alignment=&#8221;center&#8221; uncode_shortcode_id=&#8221;121070&#8243;][vc_single_image media=&#8221;138512&#8243; media_width_percent=&#8221;85&#8243; alignment=&#8221;center&#8221; uncode_shortcode_id=&#8221;868346&#8243;][\/vc_column_inner][\/vc_row_inner][vc_empty_space empty_h=&#8221;3&#8243;][vc_row_inner limit_content=&#8221;&#8221;][vc_column_inner column_width_percent=&#8221;100&#8243; align_horizontal=&#8221;align_center&#8221; gutter_size=&#8221;3&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; width=&#8221;1\/1&#8243; uncode_shortcode_id=&#8221;888870&#8243;][vc_button border_width=&#8221;0&#8243; link=&#8221;url:https%3A%2F%2Fes-us.stg.strategist3trial.com%2Fpreguntas-frecuentes%2F|title:FAQs&#8221; uncode_shortcode_id=&#8221;110297&#8243;]FAQs[\/vc_button][vc_empty_space empty_h=&#8221;3&#8243;][\/vc_column_inner][\/vc_row_inner][\/vc_column][\/vc_row][vc_row row_height_percent=&#8221;0&#8243; override_padding=&#8221;yes&#8221; h_padding=&#8221;2&#8243; top_padding=&#8221;3&#8243; bottom_padding=&#8221;3&#8243; back_color=&#8221;color-xsdn&#8221; back_image=&#8221;111788&#8243; parallax=&#8221;yes&#8221; overlay_alpha=&#8221;50&#8243; gutter_size=&#8221;3&#8243; column_width_percent=&#8221;100&#8243; shift_y=&#8221;0&#8243; z_index=&#8221;0&#8243; enable_top_divider=&#8221;default&#8221; top_divider=&#8221;tilt&#8221; shape_top_h_use_pixel=&#8221;&#8221; shape_top_height=&#8221;100&#8243; shape_top_opacity=&#8221;100&#8243; shape_top_index=&#8221;0&#8243; enable_bottom_divider=&#8221;default&#8221; bottom_divider=&#8221;tilt&#8221; shape_bottom_h_use_pixel=&#8221;&#8221; shape_bottom_height=&#8221;100&#8243; shape_bottom_opacity=&#8221;100&#8243; shape_bottom_index=&#8221;0&#8243; desktop_visibility=&#8221;yes&#8221; medium_visibility=&#8221;yes&#8221; mobile_visibility=&#8221;yes&#8221; uncode_shortcode_id=&#8221;155709&#8243; back_color_type=&#8221;uncode-palette&#8221; row_name=&#8221;locations&#8221;][vc_column column_width_use_pixel=&#8221;yes&#8221; align_horizontal=&#8221;align_center&#8221; gutter_size=&#8221;3&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; width=&#8221;1\/1&#8243; uncode_shortcode_id=&#8221;881793&#8243; column_width_pixel=&#8221;900&#8243;][vc_empty_space][vc_custom_heading text_size=&#8221;&#8221; uncode_shortcode_id=&#8221;176181&#8243;]<span style=\"font-weight: 400\">\u00bfLe interesa obtener m\u00e1s informaci\u00f3n? <\/span>[\/vc_custom_heading][vc_column_text uncode_shortcode_id=&#8221;183639&#8243;]<span style=\"font-weight: 400\">Hable con su m\u00e9dico para obtener m\u00e1s informaci\u00f3n y haga clic en el v\u00ednculo a continuaci\u00f3n para encontrar un centro del ensayo StrateGIST 1 cercano.<\/span>[\/vc_column_text][vc_column_text uncode_shortcode_id=&#8221;654154&#8243;]<b>La participaci\u00f3n en el ensayo es voluntaria y puede decidir retirarse en cualquier momento.<\/b>[\/vc_column_text][vc_empty_space empty_h=&#8221;2&#8243;][vc_button button_color=&#8221;color-773321&#8243; border_animation=&#8221;btn-ripple-out&#8221; border_width=&#8221;0&#8243; uncode_shortcode_id=&#8221;214268&#8243; link=&#8221;url:https%3A%2F%2Fstg.strategisttrials.com%2Ffaqs%2F|title:FAQs|&#8221; button_color_type=&#8221;uncode-palette&#8221;]Encuentre un centro del ensayo cl\u00ednico[\/vc_button][vc_empty_space empty_h=&#8221;5&#8243;][\/vc_column][\/vc_row][vc_row row_height_percent=&#8221;0&#8243; override_padding=&#8221;yes&#8221; h_padding=&#8221;2&#8243; top_padding=&#8221;3&#8243; bottom_padding=&#8221;3&#8243; back_color=&#8221;color-xsdn&#8221; overlay_alpha=&#8221;50&#8243; gutter_size=&#8221;3&#8243; column_width_percent=&#8221;100&#8243; shift_y=&#8221;0&#8243; z_index=&#8221;0&#8243; uncode_shortcode_id=&#8221;936538&#8243; back_color_type=&#8221;uncode-palette&#8221; row_name=&#8221;location&#8221;][vc_column column_width_use_pixel=&#8221;yes&#8221; align_horizontal=&#8221;align_center&#8221; gutter_size=&#8221;3&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; width=&#8221;1\/1&#8243; uncode_shortcode_id=&#8221;881793&#8243; column_width_pixel=&#8221;900&#8243;][vc_custom_heading text_size=&#8221;&#8221; uncode_shortcode_id=&#8221;118699&#8243;]\u00bfLe interesa obtener m\u00e1s informaci\u00f3n?[\/vc_custom_heading][vc_column_text uncode_shortcode_id=&#8221;116141&#8243;]<span style=\"font-weight: 400;\">Consulte con su m\u00e9dico para obtener m\u00e1s informaci\u00f3n sobre StrateGIST 3.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Tambi\u00e9n puede hacer clic en una ubicaci\u00f3n del mapa de abajo para encontrar un centro StrateGIST 3 cerca de usted. StrateGIST 3 estar\u00e1 disponible en hasta 150 centros de ensayos cl\u00ednicos de todo el mundo.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Se reembolsar\u00e1n los gastos de viaje relacionados con las visitas del estudio.<\/span>[\/vc_column_text][\/vc_column][\/vc_row][vc_row row_height_percent=&#8221;0&#8243; override_padding=&#8221;yes&#8221; h_padding=&#8221;2&#8243; top_padding=&#8221;2&#8243; bottom_padding=&#8221;5&#8243; back_color=&#8221;color-xsdn&#8221; overlay_alpha=&#8221;50&#8243; gutter_size=&#8221;3&#8243; column_width_percent=&#8221;100&#8243; shift_y=&#8221;0&#8243; z_index=&#8221;0&#8243; uncode_shortcode_id=&#8221;150898&#8243; back_color_type=&#8221;uncode-palette&#8221;][vc_column width=&#8221;1\/1&#8243;][vc_column_text uncode_shortcode_id=&#8221;326645&#8243;]                <script>\r\n                    const mapStyle = [];\r\n                    const marker_icon = '';\r\n                <\/script>\r\n\t\t\t            <div class=\"store-info-container \">\r\n                <div class=\"store-locations\">\r\n                    <div class=\"store-locations-search OneLinkTx\">\r\n                        <form role=\"search\" class=\"store-search-form\">\r\n                            <label for=\"search-text\"><\/label>\r\n                            <input type=\"text\" value name=\"search-text\" id=\"search-text\"\r\n                                   placeholder=\"Enter a location\">\r\n                            <input type=\"image\" id=\"search-btn\" alt=\"Search\" src=\"https:\/\/stg.strategist3trial.com\/wp-content\/plugins\/jh-wp-site-listing-main\/images\/icon-arrow-right.svg\">\r\n                            <input type=\"hidden\" id=\"place_lat\" value=\"\">\r\n                            <input type=\"hidden\" id=\"place_lng\" value=\"\">\r\n                            <input type=\"hidden\" id=\"show_map\" name=\"show_map\"\r\n                                   value=\"yes\">\r\n\t\t\t\t\t\t\t                            <input type=\"hidden\" id=\"language_code\" value=\"es-us\">\r\n                        <\/form>\r\n\t\t\t\t\t\t                            <div class=\"my-location\">\r\n                                <a href=\"javascript:void(0);\" onClick=\"getuser_location();\">\r\n\t\t\t\t\t\t\t\t\tUse my Location                                <\/a>\r\n                            <\/div>\r\n\t\t\t\t\t\t                    <\/div>\r\n                    <h5 class=\"store-locations-result-info OneLinkTx\">\r\n\t\t\t\t\t\tShowing                        <span id=\"found-results\"> 0<\/span> Results Near You                    <\/h5>\r\n\t\t\t\t\t                    <div class=\"store-locations-list\" id=\"ajax_results_wrapper\">\r\n                    <\/div>\r\n                <\/div>\r\n\t\t\t\t                    <div class=\"store-map-wrapper\">\r\n                        <div id=\"store-map\">\r\n                        <\/div>\r\n                    <\/div>\r\n\t\t\t\t            <\/div>\r\n\t\t\t[\/vc_column_text][\/vc_column][\/vc_row][vc_row row_height_percent=&#8221;0&#8243; overlay_alpha=&#8221;50&#8243; gutter_size=&#8221;3&#8243; column_width_percent=&#8221;100&#8243; shift_y=&#8221;0&#8243; z_index=&#8221;0&#8243; desktop_visibility=&#8221;yes&#8221; medium_visibility=&#8221;yes&#8221; mobile_visibility=&#8221;yes&#8221; uncode_shortcode_id=&#8221;107948&#8243;][vc_column width=&#8221;1\/1&#8243;][vc_row_inner limit_content=&#8221;&#8221;][vc_column_inner column_width_percent=&#8221;100&#8243; align_horizontal=&#8221;align_center&#8221; gutter_size=&#8221;3&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; width=&#8221;1\/4&#8243; uncode_shortcode_id=&#8221;136670&#8243;][vc_raw_html]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[\/vc_raw_html][vc_custom_heading heading_semantic=&#8221;h3&#8243; text_size=&#8221;h3&#8243; uncode_shortcode_id=&#8221;961362&#8243; subheading=&#8221;(obtenga informaci\u00f3n sobre el ensayo y acepte participar)&#8221;]Consentimiento informado[\/vc_custom_heading][\/vc_column_inner][vc_column_inner column_width_percent=&#8221;100&#8243; align_horizontal=&#8221;align_center&#8221; gutter_size=&#8221;3&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; width=&#8221;1\/4&#8243; uncode_shortcode_id=&#8221;443498&#8243;][vc_raw_html]W3Rvb2x0aXBzIGtleXdvcmQgPSAiPGltZyBzcmM9Imh0dHBzOi8vc3RnLnN0cmF0ZWdpc3QxdHJpYWwuY29tL3dwLWNvbnRlbnQvdXBsb2Fkcy8yMDI0LzExL2hlYWx0aC1zdGF0dXMucG5nIi8+IiBjb250ZW50ID0gIjxoMz5TZWxlY2Npw7NuPC9oMz48ZGl2PjxoNj5QYXJhIHZlciBzaSBjYWxpZmljYSwgdGVuZHLDoSBhbCBtZW5vcyAxIHZpc2l0YSBhbCBjZW50cm8gZGVsIGVzdHVkaW8gcGFyYSByZXNwb25kZXIgYSBwcmVndW50YXMgc29icmUgc3Ugc2FsdWQgeSBsb3MgbWVkaWNhbWVudG9zIHF1ZSB0b21hLCB5IHBhcmEgc29tZXRlcnNlIGEgYWxndW5hcyBwcnVlYmFzLjwvaDY+PGJyPjxicj48L2Rpdj4iXQ==[\/vc_raw_html][vc_custom_heading heading_semantic=&#8221;h3&#8243; text_size=&#8221;h3&#8243; uncode_shortcode_id=&#8221;927570&#8243; subheading=&#8221;(vea si califica)&#8221;]Selecci\u00f3n[\/vc_custom_heading][\/vc_column_inner][vc_column_inner column_width_percent=&#8221;100&#8243; align_horizontal=&#8221;align_center&#8221; gutter_size=&#8221;3&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; width=&#8221;1\/4&#8243; uncode_shortcode_id=&#8221;755785&#8243;][vc_raw_html]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[\/vc_raw_html][vc_custom_heading heading_semantic=&#8221;h3&#8243; text_size=&#8221;h3&#8243; uncode_shortcode_id=&#8221;665102&#8243; subheading=&#8221;IDRX-42 o sunitinib&#8221;]Tratamiento del estudio[\/vc_custom_heading][\/vc_column_inner][vc_column_inner column_width_percent=&#8221;100&#8243; align_horizontal=&#8221;align_center&#8221; gutter_size=&#8221;3&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; width=&#8221;1\/4&#8243; uncode_shortcode_id=&#8221;127480&#8243;][vc_raw_html]W3Rvb2x0aXBzIGtleXdvcmQgPSAiPGltZyBzcmM9Imh0dHBzOi8vc3RnLnN0cmF0ZWdpc3QxdHJpYWwuY29tL3dwLWNvbnRlbnQvdXBsb2Fkcy8yMDI0LzExL0FnZS5wbmciLz4iIGNvbnRlbnQgPSAiPGgyPlNlZ3VpbWllbnRvPC9oMj48ZGl2PjxoNj5VbmEgdmV6IHF1ZSB1c3RlZCB5IHN1IG3DqWRpY28gZGVjaWRhbiBpbnRlcnJ1bXBpciBlbCB0cmF0YW1pZW50byBkZWwgZXN0dWRpbywgdGVuZHLDoSAyIHZpc2l0YXMgbcOhcyB5IG1hbnRlbmRyw6EgbGxhbWFkYXMgdGVsZWbDs25pY2FzIGNvbiBlbCBlcXVpcG8gZGVsIGVzdHVkaW8gY2FkYSAzIG1lc2VzLjwvaDY+PGJyPjxicj48L2Rpdj4iXQ==[\/vc_raw_html][vc_custom_heading heading_semantic=&#8221;h3&#8243; text_size=&#8221;h3&#8243; uncode_shortcode_id=&#8221;152286&#8243;]Seguimiento[\/vc_custom_heading][\/vc_column_inner][\/vc_row_inner][\/vc_column][\/vc_row]<\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"<p>[vc_row row_height_percent=&#8221;100&#8243; back_color=&#8221;color-138503&#8243; back_image=&#8221;112255&#8243; back_repeat=&#8221;no-repeat&#8221; back_attachment=&#8221;scroll&#8221; back_position=&#8221;center center&#8221; parallax=&#8221;yes&#8221; overlay_alpha=&#8221;50&#8243; gutter_size=&#8221;4&#8243; column_width_percent=&#8221;100&#8243; shift_y=&#8221;0&#8243; z_index=&#8221;0&#8243; enable_bottom_divider=&#8221;default&#8221; bottom_divider_inv=&#8221;tilt&#8221; shape_bottom_invert=&#8221;yes&#8221; shape_bottom_flip=&#8221;yes&#8221; shape_bottom_h_use_pixel=&#8221;&#8221; shape_bottom_height=&#8221;100&#8243; [&hellip;]<\/p>\n","protected":false},"author":4,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-141342","page","type-page","status-publish","hentry"],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/stg.strategist3trial.com\/es-us\/wp-json\/wp\/v2\/pages\/141342","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/stg.strategist3trial.com\/es-us\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/stg.strategist3trial.com\/es-us\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/stg.strategist3trial.com\/es-us\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/stg.strategist3trial.com\/es-us\/wp-json\/wp\/v2\/comments?post=141342"}],"version-history":[{"count":0,"href":"https:\/\/stg.strategist3trial.com\/es-us\/wp-json\/wp\/v2\/pages\/141342\/revisions"}],"wp:attachment":[{"href":"https:\/\/stg.strategist3trial.com\/es-us\/wp-json\/wp\/v2\/media?parent=141342"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}